In the context of brain cancer related radiosensitizer research, chemoradiation investigations were prominent in the 20th century, while articles from the 21st century highlight nanoparticles, ATM inhibitors, mTOR inhibitors and inhibition of PARP. This evidence concerns the gene ATM and brain cancer.